LDHA was also associated with a poor prognosis in pancreatic cancer by regulating the expression of L-2 hydroxyglutarate, an epigenetic modifier, which can inhibit T cell proliferation and migration and thereby contribute to immune escape (Gupta et al., 2021). This evidence concerns the gene LDHA and pancreatic neoplasm.